Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 83.79% vs 25.77% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is -12.32% vs 64.99% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is -11.80% vs 66.59% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is -14.81% vs 12.50% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Rhythm Pharmaceuticals, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 4.89% vs 11.70% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 83.79% vs 25.77% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -17.05% vs 10.21% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -12.32% vs 64.99% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is -11.32% vs 10.52% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -11.80% vs 66.59% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 0.00% vs -2.13% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -14.81% vs 12.50% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






